Mason Street Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Mason Street Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-134,646	Closed	-$4.34M	–	1927
2014 Q4	$4.34M	Hold	134,646	–	–	0.03%	596
2014 Q3	$3.29M	Hold	134,646	–	–	0.03%	700
2014 Q2	$2.39M	Hold	134,646	–	–	0.02%	867
2014 Q1	$2.69M	Hold	134,646	–	–	0.02%	811
2013 Q4	$2.26M	Hold	134,646	–	–	0.02%	881
2013 Q3	$1.43M	Buy	+134,646	New	+$1.18M	0.02%	841

Other funds holding ANAC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

Mason Street Advisors's ANAC Position: Q1 2015 in Review

Mason Street Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2015, closing a stake of 134,646 shares — an estimated $4.34M sold.

Mason Street Advisors first reported a position in ANAC in Q3 2013 and held it in 6 quarters. The position peaked at $4.34M in Q4 2014. 157 funds tracked by Wall St. Rank hold ANAC as of Q1 2015.

Mason Street Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2015 after selling out during the quarter.
Mason Street Advisors sold 134,646 ANACOR PHARMACEUTICALS INC COM shares in Q1 2015, an estimated $4.34M.
Mason Street Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 6 quarters.
Mason Street Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $4.34M in Q4 2014.
157 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2015.

Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.